CLOs on the Move

Surgery Partners

www.surgerypartners.com

 
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Spencer Clark
 SVP and General Counsel Profile
Roxanne Womack
 SVP, Chief Compliance Officer Profile
Spencer Clark
 VP and Senior Legal Counsel Profile
Kelly Whelan
 VP and Senior Legal Counsel, American and Eastern Groups Profile

Similar Companies

Sunyard

Sunyard is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encore Research Group

Encore Research Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Meadow Lawn Nursing Ctr

Meadow Lawn Nursing Ctr is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Center For Growth and Healing

Center For Growth & Healing is a Kenmore, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.